<SEC-DOCUMENT>0001144204-16-123240.txt : 20160908
<SEC-HEADER>0001144204-16-123240.hdr.sgml : 20160908
<ACCEPTANCE-DATETIME>20160908163020
ACCESSION NUMBER:		0001144204-16-123240
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20160908
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20160908
DATE AS OF CHANGE:		20160908

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MEDIFAST INC
		CENTRAL INDEX KEY:			0000910329
		STANDARD INDUSTRIAL CLASSIFICATION:	MISCELLANEOUS FOOD PREPARATIONS & KINDRED PRODUCTS [2090]
		IRS NUMBER:				133714405
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-31573
		FILM NUMBER:		161876504

	BUSINESS ADDRESS:	
		STREET 1:		11445 CRONHILL DRIVE
		CITY:			OWINGS MILLS
		STATE:			MD
		ZIP:			21117
		BUSINESS PHONE:		7327640619

	MAIL ADDRESS:	
		STREET 1:		11445 CRONHILL DRIVE
		CITY:			OWINGS MILLS
		STATE:			MD
		ZIP:			21117

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HEALTHRITE INC
		DATE OF NAME CHANGE:	19951120

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	XX
		DATE OF NAME CHANGE:	19950619

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	00
		DATE OF NAME CHANGE:	19950619
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>v448442_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNITED STATES<BR>
SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Washington, DC 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM&nbsp;8-K</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CURRENT REPORT<BR>
Pursuant to Section 13 or 15(d)<BR>
of the Securities Exchange Act of 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;&#9;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Date of Report (Date of earliest event reported):
<B>September 8, 2016</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>MEDIFAST, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Exact name of registrant as specified in
its Charter)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR>
    <TD STYLE="vertical-align: top; width: 32%; padding-right: 0.8pt; text-decoration: underline; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Delaware</U></B></FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 1%; padding-right: 0.8pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 33%; padding-right: 0.8pt; text-decoration: underline; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>001-31573</U></B></FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 2%; padding-right: 0.8pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 32%; padding-right: 0.8pt; text-decoration: underline; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>13-3714405</U></B></FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 0.8pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State or other jurisdiction</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0.8pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 0.8pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Commission file number)</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0.8pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 0.8pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(IRS Employer</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 0.8pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">of incorporation)</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0.8pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 0.8pt; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0.8pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 0.8pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identification No.)</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 0.8pt; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0.8pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 0.8pt; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0.8pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 0.8pt; text-align: center">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0; text-align: center"><B><U>3600 Crondall Lane, Owings
        Mills, Maryland</U></B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0; text-align: center">(Address of Principal Executive
        Offices)</P></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0.8pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 0.8pt; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0.8pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0; text-align: center"><B><U>21117</U></B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0; text-align: center">(Zip Code)</P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Registrant&rsquo;s telephone number, including
area code: <B><U>(410)-581-8042</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>N/A</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Former Name or Former Address, if Changed
Since Last Report)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Check the appropriate box below if the Form 8-K is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (See General Instruction
A.2. below):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0%"></TD>
    <TD STYLE="width: 5%; padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-family: Wingdings">&#168;</FONT></FONT></TD>
    <TD STYLE="width: 95%; padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written communications pursuant to Rule&nbsp;425 under the Securities Act (17 CFR 230.425)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0%"></TD>
    <TD STYLE="width: 5%; padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-family: Wingdings">&#168;</FONT></FONT></TD>
    <TD STYLE="width: 95%; padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting material pursuant to Rule&nbsp;14a-12 under the Exchange Act (17 CFR 240.14a-12)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0%"></TD>
    <TD STYLE="width: 5%; padding-right: 0.8pt"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD>
    <TD STYLE="width: 95%; padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement communications pursuant to Rule&nbsp;14d-2(b)&nbsp;under the Exchange Act (17 CFR 240.14d-2(b))</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0%"></TD>
    <TD STYLE="width: 5%; padding-right: 0.8pt"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD>
    <TD STYLE="width: 95%; padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement communications pursuant to Rule&nbsp;13e-4(c)&nbsp;under the Exchange Act (17 CFR 240.13e-4(c))</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo; Options: Hidden -->&nbsp;<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0%"></TD>
    <TD STYLE="width: 10%; padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Item 8.01.</B></FONT></TD>
    <TD STYLE="width: 90%; padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Other Events.</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On September 8, 2016, Medifast, Inc. issued a press release
announcing the declaration of a cash dividend by the company&rsquo;s Board of Directors. The full text of the press release is
attached as Exhibit 99.1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0%"></TD>
    <TD STYLE="width: 10%; padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Item 9.01.</B></FONT></TD>
    <TD STYLE="width: 90%; padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Financial Statements and Exhibits.</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0%"></TD>
    <TD STYLE="width: 5%; padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD>
    <TD STYLE="width: 95%; padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Exhibits.</I></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 5%; padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</FONT></TD>
    <TD STYLE="width: 90%; padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Press
    release dated September 8, 2016 titled &ldquo;Medifast, Inc. Announces Quarterly Dividend&rdquo;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Signature</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-right: 1.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">MEDIFAST,&nbsp;INC.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-right: 1.8pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-right: 1.8pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; padding-right: 0.8pt">&nbsp;</TD>
    <TD STYLE="width: 3%; padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="width: 47%; border-bottom: black 1pt solid; padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Timothy Robinson</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0.8pt">&nbsp;</TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0">Timothy Robinson</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0">Chief Financial Officer</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-right: 1.8pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated: September 8, 2016</FONT></TD>
    <TD COLSPAN="2" STYLE="padding-right: 1.8pt">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT INDEX</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR>
    <TD STYLE="vertical-align: top; width: 0%; padding-bottom: 0"></TD>
    <TD STYLE="vertical-align: top; width: 10%; padding-right: 0.8pt; text-decoration: underline; padding-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Exhibit No.</U></B></FONT></TD>
    <TD STYLE="vertical-align: top; width: 10%; padding-right: 0.8pt; text-decoration: underline; padding-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Description</U></B></FONT></TD>
    <TD STYLE="padding-bottom: 0; width: 80%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD></TD>
    <TD STYLE="padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</FONT></TD>
    <TD COLSPAN="2" STYLE="padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Press
    Release dated September 8, 2016 titled &ldquo;Medifast, Inc. Announces Quarterly Dividend&rdquo;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="margin: 0"></P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>v448442_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 99.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;<IMG SRC="image_002.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Medifast, Inc. Announces Quarterly Dividend</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">OWINGS MILLS, Md., September 8, 2016 /PRNewswire/ -- Medifast,
Inc. (NYSE: MED), a leading United States manufacturer and provider of clinically proven weight-loss and healthy living products
and programs, announced today that its Board of Directors has approved the declaration of a $0.25 cash dividend to its stockholders.
The quarterly cash dividend of $0.25 per share is payable on November 10, 2016 to stockholders of record as of the close of business
on September 23, 2016.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company expects to maintain a program of paying dividends
on a quarterly basis. However, the declaration of dividends in the future is subject to the discretion of the Medifast Board of
Directors, who will evaluate the Company&rsquo;s dividend program from time to time based on factors that it deems relevant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white"><B>About&nbsp;Medifast&reg;:</B></FONT><BR>
<FONT STYLE="background-color: white">Medifast&nbsp;(NYSE:&nbsp;MED) </FONT><FONT STYLE="color: #222222">is the leading easy-to-use,
clinically proven provider of weight-loss and healthy living products and programs. Medifast aims to help customers lead a healthier
lifestyle through a holistic approach to weight-loss and weight management, nutrition education and fitness. Medifast&rsquo;s proven
results are based on the use of structured meal plans featuring Medifast Meals, which are nutritionally designed to assist customers
with successful weight-loss and weight management.&nbsp;The company sells its products and programs via four unique distribution
channels: 1) the web and national call centers, 2) the Take Shape For Life personal coaching division, </FONT><FONT STYLE="background-color: white">3)&nbsp;Medifast&nbsp;</FONT><FONT STYLE="color: #222222">Weight
Control Centers, and 4) a national network of physicians. The company also offers sports nutrition products under the brand Dual
Fuel&trade; Nutrition that are formulated to provide athletes and active individuals with the right balance of carbohydrates and
high quality protein for top performance.</FONT><FONT STYLE="color: blue">&nbsp;</FONT><FONT STYLE="background-color: white">&nbsp;Medifast&nbsp;was
founded in 1980 and is located in Owings Mills,&nbsp;Maryland. For more information, log onto&nbsp;www.MedifastNow.com.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">MED-F</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Forward Looking Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">This release contains &quot;forward-looking&rdquo; statements
within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934,
as amended, and the Private Securities Litigation Reform Act of 1995. These &ldquo;forward-looking&rdquo; statements are based
on present circumstances and on Medifast's predictions with respect to events that have not occurred, that may not occur, or that
may occur with different consequences and timing than those now assumed or anticipated. Such forward-looking statements, including
the expected future payment of dividends and any statement of the plans and objectives of management for future operations and
forecasts of future growth and value, are not guarantees of future performance or results and involve risks and uncertainties that
could cause actual events or results to differ materially from the events or results described in the forward-looking statements.
Such forward-looking statements are made only as of the date of this release and Medifast assumes no obligation to update forward-looking
statements to reflect subsequent events or circumstances. Readers should not place undue reliance on these forward-looking statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.85pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Investor Contact:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">ICR, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Katie Turner</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(646) 277-1228</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_002.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  Z 0$# 2(  A$! Q$!_\0
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MPQJ5S97 "7$4,>XY'1U(R"1D_4&M+XF76L>,8-/MM-\*ZXD=N[2.\]H5))&
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1^R6W_/O%_P!\"BIJ*+@?_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
